Implications of Cyclophosphamide, Methotrexate, and 5-Flurouracil Chemotherapy on Hippocampal-Dependent Cognition and Gut-Microbiome: Revised

Christa CorleyChase SwintonAntiño Recio Allen^*Bhavana SridharanTaylor McElroyJustin ThomasBailey CroninVijayalakshmi SridharanMichael Scott Robeson^*

• University of Arkansas for Medical Sciences, Little Rock, United States

Chemotherapy-induced cognitive impairment, also called “chemobrain”, has been heavily researched as a major side effect of cancer treatment. Although breast cancer has a 91% survival rate in the U.S., this rate is significantly lower in developing countries. Cancer survivors often experience chemobrain which can decrease their quality-of-life post-chemotherapy. The presented study evaluates potential mechanisms for long-term symptoms in cyclophosphamide, methotrexate, and 5-fluorouracil (CMF)-induced cognitive impairments and implications of CMF on the microbiome. Twelve-week-old C57/B6J female mice were treated with a combination of CMF once a week for 4 weeks. Spatial memory was tested with the Morris water maze. Hippocampal tissues were used to probe for immediate-early genes (IEGs) with western blotting techniques. Fecal matter was collected to assess microbial community composition via 16S rRNA gene sequencing. In this study, we showed that chemotherapy impaired spatial memory during the Morris water maze trials and resulted in a significant decrease in immediate early genes (IEGs) c-Fos, Arc, and Zif286 expression. Comparing Alpha diversity, there were no significant differences identified amongst taxa within the CMF group compared to the saline group for Pielou’s evenness. However, Beta diversity qualitative metrics, Jaccard and Unweighted Unifrac were significantly different. These results suggest that continual memory deficits may be associated with alterations in synaptic plasticity and long-term potentiation.